| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1592/PHCO.29.11.1326 |
| P698 | PubMed publication ID | 19857149 |
| P2093 | author name string | Audrey Wanger | |
| John F Mohr | |||
| Kristi M Kuper | |||
| Deborah M Boles | |||
| P2860 | cites work | Plasmid-determined AmpC-type beta-lactamases | Q24535748 |
| Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat | Q24550671 | ||
| Antimicrobial susceptibility testing: special needs for fastidious organisms and difficult-to-detect resistance mechanisms. | Q33921373 | ||
| Vancomycin-resistant enterococci | Q33975592 | ||
| Evaluation of different laboratory tests for the detection of metallo-beta-lactamase production in Enterobacteriaceae | Q46789144 | ||
| Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia | Q46826194 | ||
| Detection of mecA-mediated resistance using reference and commercial testing methods in a collection of Staphylococcus aureus expressing borderline oxacillin MICs. | Q51082163 | ||
| New consensus guidelines from the Clinical and Laboratory Standards Institute for antimicrobial susceptibility testing of infrequently isolated or fastidious bacteria. | Q51093489 | ||
| Pharmacokinetic/pharmacodynamic modeling can help guide targeted antimicrobial therapy for nosocomial gram-negative infections in critically ill patients. | Q52003283 | ||
| Comparison of two commercial systems (Vitek and MicroScan-WalkAway) for antimicrobial susceptibility testing of Pseudomonas aeruginosa isolates from cystic fibrosis patients. | Q54004912 | ||
| Transcription of the gene mediating methicillin resistance in Staphylococcus aureus (mecA) is corepressed but not coinduced by cognate mecA and beta-lactamase regulators | Q33997117 | ||
| Analysis of the comparative workflow and performance characteristics of the VITEK 2 and Phoenix systems | Q34041896 | ||
| Inadequate antimicrobial treatment: an important determinant of outcome for hospitalized patients | Q34052619 | ||
| Accuracy of three automated systems (MicroScan WalkAway, VITEK, and VITEK 2) for susceptibility testing of Pseudomonas aeruginosa against five broad-spectrum beta-lactam agents | Q34431957 | ||
| The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting | Q34509624 | ||
| Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship | Q34591740 | ||
| Metallo-beta-lactamase detection: comparative evaluation of double-disk synergy versus combined disk tests for IMP-, GIM-, SIM-, SPM-, or VIM-producing isolates | Q34759003 | ||
| Has antifungal susceptibility testing come of age? | Q34923038 | ||
| Validation of the Automated Reading and Incubation System with Sensititre Plates for Antimicrobial Susceptibility Testing | Q34991670 | ||
| Staphylococcus aureus with Heterogeneous Resistance to Vancomycin: Epidemiology, Clinical Significance, and Critical Assessment of Diagnostic Methods | Q35541702 | ||
| Utility of NCCLS guidelines for identifying extended-spectrum beta-lactamases in non-Escherichia coli and Non-Klebsiella spp. of Enterobacteriaceae | Q35552314 | ||
| National survey on the susceptibility of Bacteroides fragilis group: report and analysis of trends in the United States from 1997 to 2004 | Q35759014 | ||
| Carbapenem resistance in Klebsiella pneumoniae not detected by automated susceptibility testing | Q35793289 | ||
| Setting and revising antibacterial susceptibility breakpoints | Q35913176 | ||
| Multicenter comparison of the VITEK 2 antifungal susceptibility test with the CLSI broth microdilution reference method for testing amphotericin B, flucytosine, and voriconazole against Candida spp | Q36314322 | ||
| Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia | Q36856249 | ||
| Relationship between vancomycin MIC and failure among patients with methicillin-resistant Staphylococcus aureus bacteremia treated with vancomycin | Q36870858 | ||
| Rapid differentiation of methicillin-resistant Staphylococcus aureus and methicillin-susceptible Staphylococcus aureus from blood cultures by use of a direct cefoxitin disk diffusion test | Q36957992 | ||
| A study of workload units in five microbiology laboratories | Q37189277 | ||
| Evaluation of the automated phoenix system for potential routine use in the clinical microbiology laboratory. | Q37419949 | ||
| Occurrence of newer beta-lactamases in Klebsiella pneumoniae isolates from 24 U.S. hospitals | Q38454462 | ||
| Multicenter evaluation of the Etest and disk diffusion methods for differentiating daptomycin-susceptible from non-daptomycin-susceptible Staphylococcus aureus isolates | Q38474869 | ||
| Potential impact of the VITEK 2 system and the Advanced Expert System on the clinical laboratory of a university-based hospital | Q39465236 | ||
| Performance of eight methods, including two new rapid methods, for detection of oxacillin resistance in a challenge set of Staphylococcus aureus organisms | Q39466691 | ||
| Multicenter survey of the changing in vitro antimicrobial susceptibilities of clinical isolates of Bacteroides fragilis group, Prevotella, Fusobacterium, Porphyromonas, and Peptostreptococcus species | Q39476955 | ||
| Pharmacodynamics of cefepime in patients with Gram-negative infections | Q39614211 | ||
| Impact of inadequate initial antimicrobial therapy on mortality in infections due to extended-spectrum beta-lactamase-producing enterobacteriaceae: variability by site of infection | Q39721629 | ||
| Use of a Heavy Inoculum in the In Vitro Evaluation of the Anti-Staphylococcal Activity of 19 Cephalosporins | Q40618395 | ||
| Influence of disk separation distance on accuracy of the disk approximation test for detection of inducible clindamycin resistance in Staphylococcus spp. | Q41068259 | ||
| Comparative evaluation of the VITEK 2, disk diffusion, etest, broth microdilution, and agar dilution susceptibility testing methods for colistin in clinical isolates, including heteroresistant Enterobacter cloacae and Acinetobacter baumannii strains | Q41870150 | ||
| Results of disk diffusion testing with cefoxitin correlate with presence of mecA in Staphylococcus spp. | Q42536753 | ||
| Accuracy of six antimicrobial susceptibility methods for testing linezolid against staphylococci and enterococci | Q42637617 | ||
| Detection of extended-spectrum beta-lactamases among Enterobacteriaceae by use of semiautomated microbiology systems and manual detection procedures | Q42799124 | ||
| Microbiology workload | Q43011403 | ||
| Vancomycin MICs for methicillin-resistant Staphylococcus aureus isolates differ based upon the susceptibility test method used | Q43202070 | ||
| Clindamycin treatment of Staphylococcus aureus expressing inducible clindamycin resistance | Q43693151 | ||
| Outcomes analysis of delayed antibiotic treatment for hospital-acquired Staphylococcus aureus bacteremia | Q44453815 | ||
| Failure of Clindamycin Treatment of Methicillin-Resistant Staphylococcus aureus Expressing Inducible Clindamycin Resistance In Vitro | Q44616846 | ||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1326-1343 | |
| P577 | publication date | 2009-11-01 | |
| P1433 | published in | Pharmacotherapy | Q7180800 |
| P1476 | title | Antimicrobial susceptibility testing: a primer for clinicians | |
| P478 | volume | 29 |
| Q95327003 | A fidget spinner for the point-of-care diagnosis of urinary tract infection |
| Q37500145 | Antibiotic failure mediated by a resistant subpopulation in Enterobacter cloacae |
| Q38508090 | Antibiotic resistance to Propionobacterium acnes: worldwide scenario, diagnosis and management. |
| Q38061087 | Antifungal susceptibility testing: a primer for clinicians |
| Q92065357 | Antimicrobial susceptibility of bacterial isolates from ambulatory practice and from a referral hospital |
| Q38316070 | Antimicrobial susceptibility testing for bovine respiratory disease: getting more from diagnostic results |
| Q64128215 | Antimicrobial susceptibility testing of pathogens isolated from blood culture: a performance comparison of Accelerate Pheno™ and VITEK® 2 systems with the broth microdilution method |
| Q55251288 | Are Fluoroquinolones Appropriate for the Treatment of Extended-Spectrum β-Lactamase-Producing Gram-Negative Bacilli? |
| Q41048460 | Comparison of an automated system with conventional identification and antimicrobial susceptibility testing |
| Q34481734 | Development of an antimicrobial stewardship-based infectious diseases elective that incorporates human patient simulation technology |
| Q36083718 | Establishing quality control ranges for antimicrobial susceptibility testing of Escherichia coli, Pseudomonas aeruginosa, and Staphylococcus aureus: a cornerstone to develop reference strains for Korean clinical microbiology laboratories |
| Q92563144 | Heteroresistance: A cause of unexplained antibiotic treatment failure? |
| Q43475777 | How the new generations of microbiologists view the specialty |
| Q92500171 | Improved Performance Predicting Clarithromycin Resistance in Mycobacterium abscessus on an Independent Data Set |
| Q38421033 | In situ evaluation of Paenibacillus alvei in reducing carriage of Salmonella enterica serovar Newport on whole tomato plants |
| Q46939307 | Latent class comparison of test accuracy when evaluating antimicrobial susceptibility using disk diffusion and broth microdilution to test Escherichia coli and Mannheimia haemolytica isolates recovered from beef feedlot cattle. |
| Q87401026 | Potential pitfalls of basing specific antibiotic therapy on rapid susceptibility reporting |
| Q34389251 | Rapid antimicrobial susceptibility testing with electrokinetics enhanced biosensors for diagnosis of acute bacterial infections |
| Q38708035 | Rapid phenotypic antimicrobial susceptibility testing using nanoliter arrays |
| Q30541061 | Real-time optical antimicrobial susceptibility testing |
| Q95836269 | Reasons for antimicrobial treatment failures and predictive value of in-vitro susceptibility testing in veterinary practice: An overview |
| Q90370158 | Rethinking urinary antibiotic breakpoints: analysis of urinary antibiotic concentrations to treat multidrug resistant organisms |
| Q33915975 | Single cell antimicrobial susceptibility testing by confined microchannels and electrokinetic loading |
| Q40693098 | Trends in antibiotic resistance in bacterial keratitis isolates from South India |
| Q34142073 | Whole-genome sequencing to control antimicrobial resistance |
| Q91902608 | Why Can't We Just Use PCR? The Role of Genotypic versus Phenotypic Testing for Antimicrobial Resistance Testing |
Search more.